Nevertheless, at a treatment concentration of 1 μM, both inhibitors completely prevented the TGFbeta-1-induced upregulation of FAP protein and FAP enzymatic activity in U87 glioma cells (Figure 6B,D). This evidence concerns the gene FAP and central nervous system cancer.